Page 8 - James Lu News Today

/PRNewswire/ -- The Rockefeller Foundations Pandemic Prevention Institute (PPI) announced today that it will provide funding to Helix, a leader in nationwide...

/PRNewswire/ -- The Rockefeller Foundations Pandemic Prevention Institute (PPI) announced today that it will provide funding to Helix, a leader in nationwide...

Since early in the pandemic, Helix has applied its next-generation sequencing technology to help track the spread of SARS-CoV-2 via its work with the U.S. Centers for Disease Control and Prevention.

Missouri state officials failed to meet the Springfield region’s needs as the more-contagious delta variant caused a record number of COVID-19 cases and hospitalizations.

Missouri state officials failed to meet the Springfield region’s needs as the more-contagious delta variant caused a record number of COVID-19 cases and hospitalizations.

AlleyWatch Helix Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care. Founded by James Lu, Justin Kao, and Scott Burke in 2015, Helix is backed by investors that include National Institutes of Health, Mayo Clinic, Temasek Holdings, Casdin Capital, and DFJ Growth and is headquartered in San Mateo. FOUNDED:2015 FOUNDERS:James Lu, Justin Kao, Scott Burke

The round was led by Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek. The company intends to use the funds to accelerate the organization’s population genomics platform across health systems, life sciences companies, and to continue COVID-19 testing and viral surveillance efforts. Led by James Lu, MD, PhD, co-founder and CEO, Helix operates a CLIA-certified and-CAP-accredited sequencing laboratory, which powers both its Exome+® and COVID-19 viral sequenci...

Share this article SAN MATEO, Calif., June 3, 2021 /PRNewswire/ -- Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek. The $50M round will be used to accelerate the organizations population genomics platform across health systems, life sciences companies, and payers as well as power its growing COVID-19 testing and viral surve...

Share this article Share this article SAN MATEO, Calif., May 6, 2021 /PRNewswire/ -- Helix today announced that Marc Stapley, chairman and chief executive officer, will assume the role of executive chairman of the Helix Board of Directors on June 1, 2021 and James Lu, president and co-founder, will be appointed president and chief executive officer, and join the Helix Board of Directors, on the same date.  James Lu will be appointed president and chief executive officer of Helix, effective J...

Ginkgo and Helix Partner on Pooled COVID Testing for Schools The biotechnology company Ginkgo, in partnership with the diagnostics company Helix and its automated lab, aims to provide pooled COVID-19 testing programs in 2,000 school districts on the West Coast. TNS As millions of K-12 students return to in-person learning, school districts across the country have looked to pooled testing as a cost-effective means of monitoring the deadly virus. The method  – which minimizes the...